Paper35629327
Computational Investigations on the Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy.
Kumar GS and 4 others. Life (Basel), 2022. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Computational Investigations on the Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy. Papers, record 35629327. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35629327
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Computational Investigations on the Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32457487 | Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms. | Cancer Gene Ther | 2021 | https://conductscience.org/library/papers/32457487 | PubMed |
| 2 | 33946261 | Molecular Mechanism of Small-Molecule Inhibitors in Blocking the PD-1/PD-L1 Pathway through PD-L1 Dimerization. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33946261 | PubMed |
| 3 | 32692162 | Challenges and Opportunities in Cancer Drug Resistance. | Chem Rev | 2021 | https://conductscience.org/library/papers/32692162 | PubMed |
| 4 | 32162523 | Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. | J Nat Prod | 2020 | https://conductscience.org/library/papers/32162523 | PubMed |
| 5 | 26599107 | Study of the Differential Activity of Thrombin Inhibitors Using Docking, QSAR, Molecular Dynamics, and MM-GBSA. | PLoS One | 2015 | https://conductscience.org/library/papers/26599107 | PubMed |
| 6 | 31925406 | Dissecting the mechanisms of immune checkpoint therapy. | Nat Rev Immunol | 2020 | https://conductscience.org/library/papers/31925406 | PubMed |
| 7 | 32998374 | Computational and In Vitro Investigation of (-)-Epicatechin and Proanthocyanidin B2 as Inhibitors of Human Matrix Metalloproteinase 1. | Biomolecules | 2020 | https://conductscience.org/library/papers/32998374 | PubMed |
| 8 | 34256042 | Advance investigation on synthetic small-molecule inhibitors targeting PD-1/PD-L1 signaling pathway. | Life Sci | 2021 | https://conductscience.org/library/papers/34256042 | PubMed |
| 9 | 27094104 | From monoclonal antibodies to small molecules: the development of inhibitors targeting the PD-1/PD-L1 pathway. | Drug Discov Today | 2016 | https://conductscience.org/library/papers/27094104 | PubMed |
| 10 | 21591817 | Comparison of virtual high-throughput screening methods for the identification of phosphodiesterase-5 inhibitors. | J Chem Inf Model | 2011 | https://conductscience.org/library/papers/21591817 | PubMed |
| 11 | 32266087 | PD-1/PD-L1 pathway: current researches in cancer. | Am J Cancer Res | 2020 | https://conductscience.org/library/papers/32266087 | PubMed |
| 12 | 29567705 | Cancer immunotherapy using checkpoint blockade. | Science | 2018 | https://conductscience.org/library/papers/29567705 | PubMed |
| 13 | 15481986 | A docking score function for estimating ligand-protein interactions: application to acetylcholinesterase inhibition. | J Med Chem | 2004 | https://conductscience.org/library/papers/15481986 | PubMed |
| 14 | 30563830 | A Mechanism of Resistance to Antibody-Targeted Immune Attack. | Cancer Immunol Res | 2019 | https://conductscience.org/library/papers/30563830 | PubMed |
| 15 | 25491730 | The PD-1/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy. | Expert Opin Ther Targets | 2015 | https://conductscience.org/library/papers/25491730 | PubMed |
| 16 | 28937668 | Complete protein-protein association kinetics in atomic detail revealed by molecular dynamics simulations and Markov modelling. | Nat Chem | 2017 | https://conductscience.org/library/papers/28937668 | PubMed |
| 17 | 34209829 | Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells. | Cells | 2021 | https://conductscience.org/library/papers/34209829 | PubMed |
| 18 | 23579614 | Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. | J Comput Aided Mol Des | 2013 | https://conductscience.org/library/papers/23579614 | PubMed |
| 19 | 28189183 | Radiotherapy for Cancer: Present and Future. | Adv Drug Deliv Rev | 2017 | https://conductscience.org/library/papers/28189183 | PubMed |
| 20 | 35408504 | Molecular Dynamics Simulations: Advances and Applications. | Molecules | 2022 | https://conductscience.org/library/papers/35408504 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41028248 | Citronellol silver nanoconjugates as a therapeutic strategy for glioblastoma through computational and experimental evaluation. | Sci Rep | 2025 | https://conductscience.org/library/papers/41028248 | PubMed |
| 40504869 | Linalool-based silver nanoconjugates as potential therapeutics for glioblastoma: in silico and in vitro insights. | PLoS One | 2025 | https://conductscience.org/library/papers/40504869 | PubMed |
| 39867321 | Advancements in drug discovery: integrating CADD tools and drug repurposing for PD-1/PD-L1 axis inhibition. | RSC Adv | 2025 | https://conductscience.org/library/papers/39867321 | PubMed |
| 39779554 | Targeting PD-1 in Squamous Cell Carcinoma: Flavonoid-based Therapeutics Unveiled through in silico and in vitro Approaches. | Curr Comput Aided Drug Des | 2026 | https://conductscience.org/library/papers/39779554 | PubMed |
| 39564188 | Unlocking Benzosampangine's Potential: A Computational Approach to Investigating, Its Role as a PD-L1 Inhibitor in Tumor Immune Evasion via Molecular Docking, Dynamic Simulation, and ADMET Profiling. | Bioinform Biol Insights | 2024 | https://conductscience.org/library/papers/39564188 | PubMed |
| 39230480 | Innovative virtual screening of PD-L1 inhibitors: the synergy of molecular similarity, neural networks and GNINA docking. | Future Med Chem | 2024 | https://conductscience.org/library/papers/39230480 | PubMed |
| 38808724 | Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction. | Curr Comput Aided Drug Des | 2025 | https://conductscience.org/library/papers/38808724 | PubMed |
| 36982981 | Computational Approaches Drive Developments in Immune-Oncology Therapies for PD-1/PD-L1 Immune Checkpoint Inhibitors. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982981 | PubMed |
| 36938364 | A Potential Off-Target Effect of the Wnt/β-Catenin Inhibitor KYA1797K: PD-L1 Binding and Checkpoint Inhibition. | Biomed Hub | 2023 | https://conductscience.org/library/papers/36938364 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| PDCD1LG2 | 80380 | PubTator's text mining | https://conductscience.org/library/genes/80380 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35629327
GET https://conductscience.org/api/papers/v1/35629327/references?page=2